Mira Pharmaceuticals Inc (NASDAQ: MIRA) is 14.29% higher on its value in year-to-date trading and has touched a low of $0.51 and a high of $5.01 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MIRA stock was last observed hovering at around $1.10 in the last trading session, with the day’s gains setting it 0.1%.
Currently trading at $1.20, the stock is 2.08% and -11.52% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.74 million and changing 9.09% at the moment leaves the stock -3.24% off its SMA200. MIRA registered 14.29% gain for a year compared to 6-month gain of 84.62%. The firm has a 50-day simple moving average (SMA 50) of $1.3533 and a 200-day simple moving average (SMA200) of $1.24194.
The stock witnessed a -8.40% loss in the last 1 month and extending the period to 3 months gives it a 12.15%, and is 14.29% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.87% over the week and 8.83% over the month.
Mira Pharmaceuticals Inc (MIRA) has around 3 employees, a market worth around $19.87M and $0.00M in sales. Distance from 52-week low is 135.29% and -76.05% from its 52-week high. The company has generated returns on investments over the last 12 months (-314.53%).
The EPS is expected to grow by 13.54% this year
13.0 institutions hold shares in Mira Pharmaceuticals Inc (MIRA), with institutional investors hold 8.18% of the company’s shares. The shares outstanding are 16.27M, and float is at 11.05M with Short Float at 5.87%. Institutions hold 5.96% of the Float.
Mira Pharmaceuticals Inc (MIRA) Insider Activity
The most recent transaction is an insider sale by Aminov Erez, the company’s Chief Executive Officer. SEC filings show that Aminov Erez sold 55,410 shares of the company’s common stock on Nov 19 ’24 at a price of $1.39 per share for a total of $77020.0. Following the sale, the insider now owns 1.11 million shares.
Mira Pharmaceuticals Inc disclosed in a document filed with the SEC on Nov 20 ’24 that Aminov Erez (Chief Executive Officer) sold a total of 44,590 shares of the company’s common stock. The trade occurred on Nov 20 ’24 and was made at $1.27 per share for $56629.0. Following the transaction, the insider now directly holds 1.06 million shares of the MIRA stock.
Still, SEC filings show that on Nov 19 ’24, Erez Aminov (Affiliate) Proposed Sale 100,000 shares at an average price of $1.41 for $0.14 million. The insider now directly holds shares of Mira Pharmaceuticals Inc (MIRA).
